Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rumeysa Çolak
Observed names:
Rumeysa Colak,
RÜMEYSA ÇOLAK,
Çolak, Rümeysa,
Çolak, Rümeysa Sinem
Institutions:
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
Dokuz Eylül University,
Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi,
Şanlıurfa Mehmet Akif İnan Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Istanbul University
ORCID:
0000-0002-3867-0793
Observed ORCID:
0000-0002-3867-0793
OpenAlex ID:
A5065264745
Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
2020
·
Muhammet Ozer
, Goksel Bengi
, et al.
·
Medicine
·
47
The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors
2025
·
Murad Guliyev
, Ali Kaan Güren
, et al.
·
Cancers
·
17
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy
2024
·
Ezgi Değerli
, Çağatay Arslan
, et al.
·
Medicina
·
7
PDF
Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group
2024
·
Arif Akyildiz
, Melis Gultekin
, et al.
·
International Journal of Gynecological Cancer
·
6
First-Line Chemotherapy Versus CDK4/6 Inhibitors in HR-Positive, HER2-Negative Breast Cancer with Liver Metastases: A Multicenter Real-World Data
2025
·
Mehmet Cem Fidan
, Ahmet Emin Öztürk
, et al.
·
Journal of Clinical Medicine
·
5
PDF
Pathologic Response and Survival Outcomes on HER2-Low vs. HER2-Zero in Breast Cancer Receiving Neoadjuvant Chemotherapy
2025
·
Rumeysa Colak
, Caner Kapar
, et al.
·
Medicina
·
4
PDF
Complete response with trastuzumab in heavily pretreated HER2-positive metastatic salivary duct carcinoma
2025
·
Rumeysa Çolak
, Caner Kapar
, et al.
·
Anti-Cancer Drugs
·
4
The Prognostic Impact of HER2 Status and Survival Outcomes in Metastatic Triple Negative Breast Cancer
2025
·
ALPER TURKEL
, ECE BAYDAR
, et al.
·
In Vivo
·
3
PDF
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis
2025
·
Sedat Yıldırım
, Tugba Başoğlu
, et al.
·
BMC Cancer
·
2
PDF
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study
2025
·
Selin Akturk Esen
, Ismet Seven
, et al.
·
Anti-Cancer Drugs
·
2
The relationship between body mass index and survival in patients with renal cell carcinoma treated with nivolumab
2025
·
Rumeysa Çolak
, İlkay Gültürk
, et al.
·
Journal of Chemotherapy
·
2
Nivolumab Efficacy and Safety in Cancer Patients with Renal Dysfunction
2024
·
Ezgi Degerli
, Mesut Yilmaz
, et al.
·
Medical Bulletin of Haseki
·
2
PDF
Could macrocytosis predict survival In advanced breast cancer patients that were treated with CDK 4–6 inhibitors?
2024
·
Ilkay Gültürk
, Rumeysa Colak
, et al.
·
The Breast
·
2
PDF
Change in the neutrophil‐lymphocyte ratio may predict early recurrence in operated bladder cancer
2024
·
Rumeysa Çolak
, Gökmen Umut Erdem
, et al.
·
Asia-Pacific Journal of Clinical Oncology
·
2
Association between obesity and outcomes of first-line CDK4/6 inhibitor therapy in metastatic breast cancer: a multicenter real-world study
2026
·
Murat Günaltılı
, Murad Guliyev
, et al.
·
Scientific Reports
·
1
PDF
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer
2026
·
Ali Aytac
, Bilgin Demir
, et al.
·
Medicina
·
1
PDF
Bevacizumab combined with irinotecan or temozolomide in recurrent glioblastoma: a Turkish Oncology Group (TOG) study
2026
·
Sinem Akbas
, Ozkan Alan
, et al.
·
Journal of Neuro-Oncology
·
1
Assessment of Oral Capecitabine in Elderly Patients with Stage 2 Colon Cancer: Toxicity, Tolerability, and Survival Outcomes
2024
·
Ezgi Değerli
, İlkay Gültürk
, et al.
·
Istanbul Medical Journal
·
1
PDF
The efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: A multicenter study by the Turkish Oncology Group (TOG).
2024
·
Arif Akyildiz
, Melis Gultekin
, et al.
·
Journal of Clinical Oncology
·
1
Demographic features of patients followed up in COVID intensive care units during the pandemic period
2022
·
Deniz İncaman
, Rumeysa Çolak
, et al.
·
Kastamonu Medical Journal
·
1
Postmenopausal Hook Effect
2018
·
Rumeysa Çolak
, Burcu Çoban
, et al.
·
Endocrinology research and practice.
·
1
PDF
Cutaneous signs observed in diabetes mellitus patients.
2010
·
Dilek Çiçek
, Başak Kandi
, et al.
·
1
Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Tumori Journal
Author response for "Prognostic Value of CT Measured Baseline Tumor Volume in Nivolumab Treated Metastatic Renal Cell Carcinoma"
2026
·
Seher Yıldız Tacar
, Deniz Tural
, et al.
·
Publons reviews and discussion
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
2026
·
Mustafa Seyyar
, Pervin Can Şancı
, et al.
·
BMC Cancer
Show more works
View as search
Works count:
39
Citation count:
113
H-index:
5
I10-index:
2
Year
Topic
Type